Imagine corporate and securities lawyers who are as interested in your business as you are. Who understand and value it and who are prepared to work with you to create it, grow it, protect it and ultimately maximize your return on it. Who will help you to finance it, or bring it to the public markets, or eventually sell it. Imagine lawyers with passion, creativity and, most importantly, dedication. This is the essence of Lucosky Brookman.
The Firm provides sophisticated corporate counsel to clients that are involved in commercial transactions covering a broad range of complexity, from those encountered by start up companies to those experienced by companies traded on a national exchange, as well as advising on many day to day issues.
We represent issuers, underwriters, placement agents, and private investment funds in public and private offerings of equity, debt and convertible securities.
We have significant experience in mergers, acquisitions, asset exchanges, sales and divestitures, recapitalizations, and other business combination transactions.
We represent lenders and borrowers in connection with single-lender and syndicated secured and unsecured senior, subordinated and mezzanine lending transactions.
Providing sophisticated legal representation and business planning services to start-up and mature companies.
We represent mid-sized and small companies, banks, private equity firms, venture funds, investment advisors, and individuals in complex business, securities and commercial disputes.
$15,000,000 underwritten offering of common stock and dual-listing onto the NASDAQ Capital market of a New Jersey-based AIM-listed diagnostics company specializing in the development, manufacture, and supply of rapid, point-of-care screening and testing products.
$5,000,000 private placement of equity securities of an Illinois-based engineering, manufacturing and construction company specializing in designing and building athletic facilities, as well as the manufacturing of high-end synthetic turf products.
$7,500,000 offering of common stock and reverse merger of a New Jersey-based manufacturer and marketer of specialty pre-prepared, frozen and refrigerated all-natural food products.
Lucosky Brookman is pleased to announce that it raised $101,520 on behalf of the Save A Child's Heart Foundation during its inaugural charity golf outing on June 9, 2014 at the Trump National Golf Club in Colts Neck, New Jersey. For pictures of the event and for further details, please visit the Charity's Blog Post Website.
Lucosky Brookman announces that it will be co-sponsoring the Marcum MicroCap Conference to be held at the Grand Hyatt in New York City on May 29, 2014. Joseph Lucosky will speak on the IPO Boot Camp Expert Panel, an interactive workshop for founders, officers and directors of pre-IPO and recently-public emerging growth companies.
Lucosky Brookman announces that it will be co-sponsoring the 2014 Capital Growth Expo to be held in Las Vegas, Nevada from April 29, 2014 through May 1, 2014. The Capital Growth Expo is a premier event focusing on emerging growth company finance. Joseph Lucosky will serve as one of the moderators of the IPO Boot Camp and speak on an expert panel discussing the legal aspects of going-public transactions.
Lucosky Brookman issues
Legal Alert Memorandum outlining the OTC Markets Group's new eligibility standards for the
OTCQB Venture Stage Marketplace. Effective May, 1, 2014, companies will be required to meet an
initial and ongoing $0.01 per share minimum bid price test, among other requirements, in order to
remain on the OTCQB.
Lucosky Brookman publishes Desk Reference chart summarizing the 2014 SEC Filing
Deadlines for Large Accelerated, Accelerated and Non-Accelerated / Smaller Reporting Companies.
Lucosky Brookman published memorandum outlining the New York Stock Exchange’s revision
to Rule 452 that would end its prior policy of allowing brokers to vote on certain corporate governance
proposals supported by management.
Lucosky Brookman publishes memorandum pertaining to the SEC’s codification of the “Accredited Investor” Net Worth Test and the exclusion of the primary residence in determining Accredited Investor status